10
May
2009
Parasol Therapeutics, Inc.: Series A $3.25M
Posted in I - Series A, Q - 2Q09, R - NORTH EAST, X - Device (Diagnostic), X - Influenza, X - Vaccines, XX - MA
Parasol Therapeutics (Cambridge, MA) a seed-stage company focused on treatments and diagnostics for influenza, closed a $3.3M Series A financing. Participants include Polaris Venture Partners, Flagship Ventures and Lux Capital.
OnBioVC PARTNERS
-
